ema prac tirzepatide naion review 2025 EMA safety committee to review link between semaglutide and rare eye condition Idiopathic Intracranial Hypertension and the

Heart palpitations are unsettling

Lipotropic injections, although beneficial for many seeking weight loss and metabolic enhancement, are not suitable for everyone

Low-dose empagliflozin as adjunct to hybrid closed-loop insulin therapy in adults with suboptimally controlled type 1 diabetes: a randomized crossover controlled trial

If sugar levels drop too quickly, the brain cannot function properly, and dizziness may occur

If you stick to your schedule for at least a year, you could lose up to 25% of your starting weight

Other GLP-1 receptor agonists and various weight loss interventionswhether pharmacological, dietary, or surgicalare also associated with increased gallbladder-related risks, though the magnitude may vary by approach and agent